hathaway - ALNT
ALNT
Close Chg Chg %
55.40 -0.37 -0.67%
Closed Market
55.03
-0.37 (0.67%)
Volume: 250.97K
Last Updated:
Dec 15, 2025, 4:00 PM EDT
Company Overview: hathaway - ALNT
ALNT Key Data
| Open $56.42 | Day Range 55.00 - 57.67 |
| 52 Week Range 19.25 - 58.12 | Market Cap $938.67M |
| Shares Outstanding 16.94M | Public Float 14.36M |
| Beta 1.59 | Rev. Per Employee N/A |
| P/E Ratio 49.58 | EPS $1.12 |
| Yield 21.66% | Dividend $0.03 |
| EX-DIVIDEND DATE Nov 20, 2025 | SHORT INTEREST N/A |
| AVERAGE VOLUME 162.75K |
ALNT Performance
| 1 Week | -0.67% | ||
| 1 Month | 3.83% | ||
| 3 Months | 18.12% | ||
| 1 Year | 113.13% | ||
| 5 Years | N/A |
ALNT Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
4
Full Ratings ➔
About hathaway - ALNT
Allient, Inc. is a global engineering and manufacturing enterprise that develops solutions to drive the future of market-moving industries, including medical, life sciences, aerospace and defense, industrial automation, robotics, semi-conductor, transportation, agriculture, construction and facility infrastructure. The company was founded in 1962 and is headquartered in Amherst, NY.
ALNT At a Glance
Allient, Inc.
495 Commerce Drive
Amherst, New York 14228
| Phone | 1-716-242-8634 | Revenue | 529.97M | |
| Industry | Electrical Products | Net Income | 13.17M | |
| Sector | Producer Manufacturing | Employees | 2,525 | |
| Fiscal Year-end | 12 / 2025 | |||
| View SEC Filings |
ALNT Valuation
| P/E Current | 49.584 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 30.618 |
| Price to Sales Ratio | 0.761 |
| Price to Book Ratio | 1.541 |
| Price to Cash Flow Ratio | 9.63 |
| Enterprise Value to EBITDA | 10.56 |
| Enterprise Value to Sales | 1.163 |
| Total Debt to Enterprise Value | 0.404 |
ALNT Efficiency
| Revenue/Employee | 209,888.317 |
| Income Per Employee | 5,214.257 |
| Receivables Turnover | 6.728 |
| Total Asset Turnover | 0.903 |
ALNT Liquidity
| Current Ratio | 4.141 |
| Quick Ratio | 2.197 |
| Cash Ratio | 0.629 |
ALNT Profitability
| Gross Margin | 28.906 |
| Operating Margin | 6.124 |
| Pretax Margin | 3.181 |
| Net Margin | 2.484 |
| Return on Assets | 2.244 |
| Return on Equity | 5.099 |
| Return on Total Capital | 2.562 |
| Return on Invested Capital | 2.639 |
ALNT Capital Structure
| Total Debt to Total Equity | 94.063 |
| Total Debt to Total Capital | 48.47 |
| Total Debt to Total Assets | 43.268 |
| Long-Term Debt to Equity | 91.973 |
| Long-Term Debt to Total Capital | 47.393 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Hathaway - ALNT
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 403.52M | 502.99M | 578.63M | 529.97M | |
Sales Growth
| +10.04% | +24.65% | +15.04% | -8.41% | |
Cost of Goods Sold (COGS) incl D&A
| 288.70M | 356.90M | 407.26M | 376.77M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 18.11M | 23.84M | 25.07M | 25.89M | |
Depreciation
| 11.86M | 12.68M | 12.76M | 13.19M | |
Amortization of Intangibles
| 6.25M | 11.17M | 12.31M | 12.70M | |
COGS Growth
| +9.34% | +23.62% | +14.11% | -7.49% | |
Gross Income
| 114.81M | 146.09M | 171.37M | 153.19M | |
Gross Income Growth
| +11.85% | +27.24% | +17.30% | -10.61% | |
Gross Profit Margin
| +28.45% | +29.04% | +29.62% | +28.91% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 87.49M | 111.11M | 124.78M | 120.74M | |
Research & Development
| 27.82M | 38.56M | 41.66M | 39.76M | |
Other SG&A
| 59.67M | 72.55M | 83.12M | 80.98M | |
SGA Growth
| +10.49% | +27.01% | +12.30% | -3.24% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 1.30M | 11.01M | (8.11M) | (10.88M) | |
EBIT after Unusual Expense
| 26.03M | 23.96M | 54.70M | 43.33M | |
Non Operating Income/Expense
| (606.00K) | 249.00K | 3.58M | 4.31M | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 2.31M | 532.00K | 28.58M | 30.79M | |
Interest Expense Growth
| -25.07% | -76.94% | +5,272.18% | +7.72% | |
Gross Interest Expense
| 2.31M | 532.00K | 28.58M | 30.79M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| 23.11M | 23.68M | 29.70M | 16.86M | |
Pretax Income Growth
| +23.10% | +2.46% | +25.42% | -43.24% | |
Pretax Margin
| +5.73% | +4.71% | +5.13% | +3.18% | |
Income Tax
| (981.00K) | 6.29M | 5.60M | 3.69M | |
Income Tax - Current - Domestic
| 1.87M | 5.90M | 7.80M | 2.52M | |
Income Tax - Current - Foreign
| 3.29M | 4.11M | 2.83M | 3.52M | |
Income Tax - Deferred - Domestic
| 649.00K | (3.92M) | (4.09M) | (1.45M) | |
Income Tax - Deferred - Foreign
| (6.78M) | 193.00K | (949.00K) | (900.00K) | |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| - | - | - | - | - |
Consolidated Net Income
| 24.09M | 17.39M | 24.10M | 13.17M | |
Minority Interest Expense
| - | - | - | - | - |
Net Income
| 24.09M | 17.39M | 24.10M | 13.17M | |
Net Income Growth
| +76.60% | -27.83% | +38.58% | -45.36% | |
Net Margin Growth
| +5.97% | +3.46% | +4.16% | +2.48% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| 24.09M | 17.39M | 24.10M | 13.17M | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| 24.09M | 17.39M | 24.10M | 13.17M | |
EPS (Basic)
| 1.6717 | 1.1256 | 1.5096 | 0.7965 | |
EPS (Basic) Growth
| +74.52% | -32.67% | +34.12% | -47.24% | |
Basic Shares Outstanding
| 14.41M | 15.45M | 15.96M | 16.53M | |
EPS (Diluted)
| 1.6597 | 1.0902 | 1.4809 | 0.793 | |
EPS (Diluted) Growth
| +74.36% | -34.31% | +35.84% | -46.45% | |
Diluted Shares Outstanding
| 14.52M | 15.95M | 16.27M | 16.60M | |
EBITDA
| 45.43M | 58.82M | 71.66M | 58.34M | |
EBITDA Growth
| +15.16% | +29.47% | +21.82% | -18.58% | |
EBITDA Margin
| +11.26% | +11.69% | +12.38% | +11.01% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 51.318 | |
| Number of Ratings | 4 | Current Quarters Estimate | 0.458 | |
| FY Report Date | 12 / 2025 | Current Year's Estimate | 2.072 | |
| Last Quarter’s Earnings | 0.59 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 1.49 | Next Fiscal Year Estimate | 2.495 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 4 | 1 | 4 | 4 |
| Mean Estimate | 0.46 | 0.58 | 2.07 | 2.49 |
| High Estimates | 0.51 | 0.58 | 2.13 | 2.64 |
| Low Estimate | 0.43 | 0.58 | 2.04 | 2.35 |
| Coefficient of Variance | 8.35 | N/A | 2.00 | 5.66 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 2 | 2 | 2 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 2 | 2 | 1 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Hathaway - ALNT
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Hathaway - ALNT
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Apr 4, 2025 | Richard S. Warzala Chief Executive Officer; Director | 1,560,783 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $22 per share | 34,337,226.00 |
| Apr 4, 2025 | Kenneth Arthur May Chief Technology Officer | 17,672 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $22 per share | 388,784.00 |
| Apr 4, 2025 | Helmut D. Pirthauer VP and Group President | 44,501 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $22 per share | 979,022.00 |
| Apr 4, 2025 | Ashish R. Bendre VP and Group President | 38,883 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $22 per share | 855,426.00 |
| Apr 4, 2025 | Stephen Warzala VP and Group President | 33,191 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $22 per share | 730,202.00 |
| Apr 4, 2025 | Geoffery C. Rondeau VP of Operational Excellence | 14,772 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $22 per share | 324,984.00 |
| Mar 7, 2025 | James A. Michaud Chief Financial Officer | 10,950 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $23.74 per share | 259,953.00 |
| Mar 7, 2025 | James A. Michaud Chief Financial Officer | 7,301 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $23.74 per share | 173,325.74 |
| Mar 7, 2025 | Kenneth Arthur May Chief Technology Officer | 20,052 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $23.74 per share | 476,034.48 |
| Mar 7, 2025 | Stephen Warzala VP and Group President | 36,095 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $23.74 per share | 856,895.30 |
| Mar 7, 2025 | Nicole R. Tzetzo Director | 11,731 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $23.22 per share | 272,393.82 |
| Mar 7, 2025 | Geoffery C. Rondeau VP of Operational Excellence | 16,138 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $23.74 per share | 383,116.12 |
| Mar 7, 2025 | Ashish R. Bendre VP and Group President | 39,816 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $23.74 per share | 945,231.84 |
| Mar 7, 2025 | Steven C. Finch Director | 10,504 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $23.22 per share | 243,902.88 |
| Mar 7, 2025 | Richard D. Federico Director | 73,838 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $23.22 per share | 1,714,518.36 |
| Mar 7, 2025 | Robert B. Engel Director | 34,236 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $23.22 per share | 794,959.92 |
| Mar 7, 2025 | Michael R. Winter Director | 37,687 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $23.22 per share | 875,092.14 |
| Mar 7, 2025 | Richard S. Warzala Chief Executive Officer; Director | 1,600,893 | Grant, award or other acq pursuant to Rule 16b-3(d) Non-derivative transaction at $23.74 per share | 38,005,199.82 |